Free Trial
OTCMKTS:ISCO

International Stem Cell (ISCO) Stock Price, News & Analysis

International Stem Cell logo
$0.13 0.00 (0.00%)
As of 08/8/2025

About International Stem Cell Stock (OTCMKTS:ISCO)

Key Stats

Today's Range
$0.13
$0.13
50-Day Range
$0.12
$0.20
52-Week Range
$0.05
$0.27
Volume
7 shs
Average Volume
4,713 shs
Market Capitalization
$1.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ISCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for International Stem Cell and its competitors with MarketBeat's FREE daily newsletter.

ISCO Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
See More Headlines

ISCO Stock Analysis - Frequently Asked Questions

International Stem Cell's stock was trading at $0.0813 at the start of the year. Since then, ISCO stock has increased by 53.9% and is now trading at $0.1251.

International Stem Cell Corp. (OTCMKTS:ISCO) released its quarterly earnings results on Wednesday, May, 14th. The biotechnology company reported ($0.03) EPS for the quarter. The biotechnology company earned $2.13 million during the quarter.

Shares of ISCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that International Stem Cell investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Amarantus Bioscience (AMBS), Fulcrum Therapeutics (FULC), Kutcho Copper (KCCFF), B2Gold (BTG) and Cannabis Wheaton Income (CBWTF).

Company Calendar

Last Earnings
5/14/2025
Today
8/09/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:ISCO
CIK
1355790
Employees
30
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$210 thousand
Net Margins
-3.39%
Pretax Margin
-2.76%
Return on Equity
N/A
Return on Assets
-5.71%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.75
Quick Ratio
0.51

Sales & Book Value

Annual Sales
$9.09 million
Price / Sales
0.11
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.49) per share
Price / Book
-0.26

Miscellaneous

Outstanding Shares
8,000,000
Free Float
1,482,000
Market Cap
$1.00 million
Optionable
Not Optionable
Beta
-0.07

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (OTCMKTS:ISCO) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners